- Home
- NIC vs OCUL Comparison
NIC vs OCUL Comparison
Compare NIC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIC
- OCUL
- Stock Information
- Founded
- NIC 2000
- OCUL 2006
- Country
- NIC United States
- OCUL United States
- Employees
- NIC N/A
- OCUL N/A
- Industry
- NIC Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- NIC Finance
- OCUL Health Care
- Exchange
- NIC Nasdaq
- OCUL Nasdaq
- Market Cap
- NIC 1.4B
- OCUL 1.4B
- IPO Year
- NIC N/A
- OCUL 2014
- Fundamental
- Price
- NIC $111.54
- OCUL $9.16
- Analyst Decision
- NIC Hold
- OCUL Strong Buy
- Analyst Count
- NIC 5
- OCUL 8
- Target Price
- NIC $101.60
- OCUL $16.50
- AVG Volume (30 Days)
- NIC 69.7K
- OCUL 889.3K
- Earning Date
- NIC 10-15-2024
- OCUL 11-14-2024
- Dividend Yield
- NIC 1.00%
- OCUL N/A
- EPS Growth
- NIC 102.58
- OCUL N/A
- EPS
- NIC 7.86
- OCUL N/A
- Revenue
- NIC $342,790,000.00
- OCUL $61,442,000.00
- Revenue This Year
- NIC N/A
- OCUL $15.49
- Revenue Next Year
- NIC $4.63
- OCUL $13.31
- P/E Ratio
- NIC $14.22
- OCUL N/A
- Revenue Growth
- NIC 28.93
- OCUL 6.45
- 52 Week Low
- NIC $72.70
- OCUL $2.05
- 52 Week High
- NIC $116.17
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- NIC 61.73
- OCUL 34.86
- Support Level
- NIC $99.64
- OCUL $10.46
- Resistance Level
- NIC $116.17
- OCUL $11.12
- Average True Range (ATR)
- NIC 3.10
- OCUL 0.57
- MACD
- NIC 0.48
- OCUL -0.22
- Stochastic Oscillator
- NIC 71.99
- OCUL 0.60
About NIC Nicolet Bankshares Inc.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.